Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide

Area of Science:

• Neonatal surgery
• Pediatric gastroenterology

Background:

• Enterocutaneous fistulas are serious complications in neonates following duodenal perforation repair.
• Persistent fistulas pose significant management challenges in premature infants.

Purpose of the Study:

• To report the therapeutic efficacy of octreotide in a premature neonate with a persistent enterocutaneous fistula.
• To evaluate the safety of octreotide in very small infants with intestinal fistulas.

Main Methods:

• Case report of a premature newborn treated with octreotide for a persistent enterocutaneous fistula.
• Monitoring of biochemical and blood parameters during octreotide therapy.

Main Results:

• Octreotide demonstrated therapeutic effectiveness in managing the persistent fistula.
• Octreotide administration was found to be safe in this premature infant.

Conclusions:

• Octreotide is a safe and effective treatment option for persistent intestinal fistulas in premature infants.
• Close monitoring of biochemical and blood parameters is crucial for patients receiving octreotide.